Bennett researches pathogenesis, diagnosis, treatment, prevention, and epidemiology of mycoses, particularly cryptococcosis and candidiasis.[1] He also researches idiopathic CD4 lymphocytopenia and clinical trials of antifungal agents.[3] Bennett and Peter Richard Williamson are studying previously healthy patients with cryptococcal meningitis to discover underlying predisposing factors and improve therapy. Despite the absence of immunosuppression, these patients are surprisingly difficult to treat compared to those with AIDS and cryptococcosis. A major cause of morbidity and death is cerebral edema and increased intracranial pressure, which usually coexist. The goals in studying these patients include: understanding the mechanisms causing cerebral edema and increased intracranial pressure, searching for genetic markers in the patients and their families that might have predisposed patients to cryptococcosis, assessing the role of corticosteroids in controlling cerebral edema, and evaluating potential new treatments for cryptococcosis.[1]
↑"John E. Bennett, M.D."NIH: National Institute of Allergy and Infectious Diseases. Retrieved 2019-07-01. This article incorporates text from this source, which is in the public domain.